Cohen Jacob D.'s Form 4 filing
Mangoceuticals, Inc. (MGRX) · filed May 2, 2023
- Accession no.
- 0001493152-23-015227
- Filed
- May 2, 2023, 8:50 PM ET
- Trade date
- Apr 4-10, 2023
- Filing delay
- 28 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market purchases total $275.0K. It was filed 28 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Cohen Jacob D.CIK 0001432078 | Director, Officer (Chief Executive Officer), 10% Owner |
| Tiger Cub TrustCIK 0001974475 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 4, 2023 | Common Stock | GGiftDisposed | −8,000,000 | $0.00 | $0 | 0 | Indirect | |
| Apr 4, 2023 | Common Stock | GGiftAcquired | +8,000,000 | $0.00 | $0 | 8,000,000 | Direct | |
| Apr 10, 2023 | Common Stock | PPurchaseAcquired | +275,000 | $1.00 | +$275,000 | 8,275,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.